Genotyping Market By Technology (Polymerase Chain Reaction, Microarrays, Next-Generation Sequencing, Capillary Electrophoresis, MALDI-TOF, Others), By Application (Pharmacogenomics, Diagnostics & Personalized Medicine, Agriculture & Animal Research, Drug Discovery & Development, Forensic Genotyping, Others), By End-user (Pharmaceutical & Biotechnology Companies, Research & Academic Institutes, Hospitals & Diagnostic Laboratories, Contract Research Organizations), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
Published Date: Mar 2025 | Report ID: MI2295 | 210 Pages
Report Coverage:
By Technology
- Polymerase Chain Reaction (PCR)
- Microarrays
- Next-generation sequencing (NGS)
- Capillary Electrophoresis
- MALDI-TOF (Mass Spectrometry-Based Genotyping)
- Others
By Application
- Pharmacogenomics
- Diagnostics & Personalized Medicine
- Agriculture & Animal Research
- Drug Discovery & Development
- Forensic Genotyping
- Others
By End-user
- Pharmaceutical & Biotechnology Companies
- Research & Academic Institutes
- Hospitals & Diagnostic Laboratories
- Contract Research Organizations (CROs)
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East & Africa
List of Companies:
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN
- Danaher Corporation
- Hoffmann-La Roche Ltd
- Eurofins Genomics LLC
- PacBio
- Integrated DNA Technologies, Inc.
- Beckman Coulter, Inc.
- Standard BioTools
- Azenta Life Sciences
- GE HealthCare
- LGC Limited
- Azenta US, Inc.
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.